| Mrs Deborah Logan, LMFT | |
|
17111 Kenton Dr Ste 203b, Cornelius, NC 28031-5650 | |
| (704) 677-4135 | |
| Not Available |
| Full Name | Mrs Deborah Logan |
|---|---|
| Gender | Female |
| Speciality | Marriage & Family Therapist |
| Location | 17111 Kenton Dr Ste 203b, Cornelius, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114468212 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | 12018A (North Carolina) | Secondary |
| 106H00000X | Marriage & Family Therapist | 2259 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Deborah Logan, LMFT 113 Bushnell Pl, Mooresville, NC 28115-8327 Ph: () - | Mrs Deborah Logan, LMFT 17111 Kenton Dr Ste 203b, Cornelius, NC 28031-5650 Ph: (704) 677-4135 |
News Archive
He calls himself the bug hunter, but the target of his work consists of viruses that can only be found and identified with special methods and instruments.
IRIDEX Corporation announced the first commercial sales of its new Cyclo G6 laser system, designed to treat patients diagnosed with a range of glaucoma disease states. The Cyclo G6 system includes a glaucoma dedicated laser along with a family of single use probes, including the newly patented MicroPulse P3 disposable.
Cloth face coverings, even homemade masks made with the correct material, are effective in reducing the spread of COVID-19 - for the wearer and those around them - according to a new study published today from Oxford's Leverhulme Centre for Demographic Science.
AbbVie, a global biopharmaceutical company, today announced that results from a Phase 1b trial of investigational venetoclax, a novel inhibitor of the B-cell lymphoma-2 (BCL-2) protein that is being developed in partnership with Genentech and Roche, in combination with bortezomib and dexamethasone, showed an 83 percent overall response rate (n=5/6) in bortezomib-naive patients with relapsed/refractory (R/R) multiple myeloma, including two patients who achieved complete responses.1 These data will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting on Sunday, May 31, in Chicago.
› Verified 5 days ago
Bess Lyons Ceresa, M.S., L.M.F.T. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 18809 W Catawba Ave, Suite 202, Cornelius, NC 28031 Phone: 704-607-6592 | |
Amy Lowery, LMFTA Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 18637 Northline Dr Ste H, Cornelius, NC 28031 Phone: 704-765-2343 | |
Daniel Swiger, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 8122 Forest Shadow Cir, Cornelius, NC 28031 Phone: 704-728-0411 | |
Mrs. Teresa Dillard, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 18805 W Catawba Ave Ste 206, Cornelius, NC 28031 Phone: 704-995-5907 | |
Mr. Coleman James Dove, LMFT-A Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 17714 Kings Point Dr Ste A&b, Cornelius, NC 28031 Phone: 704-997-5397 | |
Deborah Pierce Rees, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 19109 W Catawba Ave, Suite 200, Cornelius, NC 28031 Phone: 704-894-9730 Fax: 704-894-9731 |